Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Merlio

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Virchows Archiv : an International Journal of Pathology|July 17, 2017
Assessment of BRAF<sup>V600E</sup> mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reactionClémence Pierry, Charline Caumont, Elodie Blanchard, et al.
The Journal of Investigative Dermatology|February 5, 2010
Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classesElodie Laharanne, Naïma Oumouhou, Françoise Bonnet, et al.
Scientific Reports|April 3, 2025
Improving diagnostic accuracy in atypical melanocytic tumors using p16 immunohistochemistry and 9p21 fluorescence in situ hybridization: analysis of 206 second opinion casesRémi Vergara, Elodie Laharanne, Arnaud de la Fouchardière, et al.
Frontiers in Oncology|November 12, 2021
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary CellsAlain Chebly, Martina Prochazkova-Carlotti, Yamina Idrissi, et al.
The American Journal of Surgical Pathology|May 29, 2004
Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomasBéatrice Vergier, Marc-Antoine Belaud-Rotureau, Marie-Noëlle Benassy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphomaElodie Laharanne, Edith Chevret, Yamina Idrissi, et al.
Pathology, Research and Practice|March 26, 2003
Cellular mesoblastic nephroma: morphologic, cytogenetic and molecular links with congenital fibrosarcomaSébastien Henno, Laurence Loeuillet, Catherine Henry, et al.
Virchows Archiv : an International Journal of Pathology|March 4, 2008
Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomasMarc-Antoine Belaud-Rotureau, Virginie Marietta, Beatrice Vergier, et al.
The American Journal of Surgical Pathology|December 3, 2002
Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cellsMarie Parrens, Béatrice Vergier, Olivier Fitoussi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphomaAnne Pham-Ledard, Martina Prochazkova-Carlotti, Laetitia Andrique, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Virchows Archiv : an International Journal of Pathology|July 17, 2017
Assessment of BRAF<sup>V600E</sup> mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reactionClémence Pierry, Charline Caumont, Elodie Blanchard, et al.
The Journal of Investigative Dermatology|February 5, 2010
Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classesElodie Laharanne, Naïma Oumouhou, Françoise Bonnet, et al.
Scientific Reports|April 3, 2025
Improving diagnostic accuracy in atypical melanocytic tumors using p16 immunohistochemistry and 9p21 fluorescence in situ hybridization: analysis of 206 second opinion casesRémi Vergara, Elodie Laharanne, Arnaud de la Fouchardière, et al.
Frontiers in Oncology|November 12, 2021
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary CellsAlain Chebly, Martina Prochazkova-Carlotti, Yamina Idrissi, et al.
The American Journal of Surgical Pathology|May 29, 2004
Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomasBéatrice Vergier, Marc-Antoine Belaud-Rotureau, Marie-Noëlle Benassy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphomaElodie Laharanne, Edith Chevret, Yamina Idrissi, et al.
Pathology, Research and Practice|March 26, 2003
Cellular mesoblastic nephroma: morphologic, cytogenetic and molecular links with congenital fibrosarcomaSébastien Henno, Laurence Loeuillet, Catherine Henry, et al.
Virchows Archiv : an International Journal of Pathology|March 4, 2008
Inactivation of p16INK4a/CDKN2A gene may be a diagnostic feature of large B cell lymphoma leg type among cutaneous B cell lymphomasMarc-Antoine Belaud-Rotureau, Virginie Marietta, Beatrice Vergier, et al.
The American Journal of Surgical Pathology|December 3, 2002
Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cellsMarie Parrens, Béatrice Vergier, Olivier Fitoussi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphomaAnne Pham-Ledard, Martina Prochazkova-Carlotti, Laetitia Andrique, et al.
Pageof 12